U.S. productivity slumps in first quarter
Unit labor costs soar by most in a year
Unit labor costs soar by most in a year
Regeneron Pharmaceuticals’ stock fell 2.6% premarket Thursday, after the drug company’s first-quarter profit and revenue fell short of analyst estimates.
Deliberately weakening social protections has created greater financial and economic insecurity.
Tech giants’ recent earnings reveal a clear winner in market leadership and momentum.
Novartis on Thursday said it will pay up to $1.75 billion for a U.S. biotech focused on cancer.
Here’s the key that could unlock the U.S. housing market for buyers and sellers.
If the property has been held for a long time things can become complicated.